Worth reading
60In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
55
¥100 million (FY2029 revenue target)Wording
Avoiding a definitive answer
How definitive the wording is.Items stated in the management plan
Annual updateNet Sales+39.3%
基準 3,949Target5,500million
Operating profit+0.2%
基準 2,025Target2,029million
ROE+4.0pt
基準 2,025Target2,029%
Each line is the climb from the baseline the document states to the target it sets. The slope is scaled against the largest climb in this document. For metrics expressed as percentages, differences are shown in percentage points (pt).The increase shown by the dotted line is calculated from the two reported figures because the company did not provide the amount of growth.
Operating profit marginNot disclosed → FY2029 target: 10% or more
Only the target level is shown because the current level for comparison was not provided.Total investment planFY2027–2029: ¥300 million
Investment amount by sectorField Investment in systems related to the membership base and databases / Amount Not disclosed, Field Investment in applying AI to employment-related operations / Amount Not disclosed
Statements about the use of capital
Self-assessment of PBR and share pricePBR was 0.7x in FY2025. The Company aims to achieve a PBR of 1x or more in FY2029 and improve its PBR.PBR is a measure of how many times the share price is the book value per share.
Key initiatives
01Expanding and activating the member base
02Expanding full-time and regular part-time placements
03Monetizing activities that leverage physicians' expertise
04Selective focus on growth areas
05Use of AI
06Activating physician members
07Significantly improving productivity
08Optimizing the sales promotion ratio
09Optimizing workforce efficiency through the use of AI
10Using the customer base
11Developing agents
12Business development and collaboration
13Converting into value assets
14Shifting the business model
15Building a model for circulating physician value overseas
Plan assumptionsFY2025 revenue and operating profit are presented excluding services exited in FY2026. Numerical assumptions such as exchange rates: not disclosed.
Segment targetSegment Opportunity Creation / Sales Target FY2029: ¥4,500 million / Profit Target Not disclosed, Segment Platform / Sales Target FY2029: ¥1,000 million / Profit Target Not disclosed
Non-financial targetsIndicator Physician information matches / Target value 500,000 matches / Timing FY2029, Indicator Registered physicians / Target value 150,000 physicians / Timing FY2029, Indicator Number of business partners / Target value 45,000 locations / Timing FY2029
Size of the Target MarketPart-time physician market: ¥8.7 billion in 2029, with 763,000 referrals across the overall market. Full-time and regular part-time physician market: ¥23.0 billion in 2029, with 22,000 referrals across the overall market. Physician-targeted market: ¥171.1 billion in 2029. Medical expenses: ¥50 trillion in 2029. Source: Prepared by the Company based on Ministry of Health, Labour and Welfare statistics and data from external research organizations.
Risks identified by the company
System Failures
Information Security
Service Operations
Changes to laws and regulations
Overseas Business
Foreign exchange
Competition
Promotion of new services and businesses
| Item | Details |
|---|---|
| Plan name | Medium-Term Management Vision |
| Plan period | FY2025～FY2029 |
| Progress against the plan | Annual update |
| Sales Target | FY2025 actual: 3,949 (Activities 3,246 + Infrastructure 703) → FY2029 target: 5,500 (Activities 4,500 + Infrastructure 1,000)（39.3%） |
| Operating profit target | FY2025 actual: 73 → FY2029 target: 550（653.4%） |
| Operating profit margin target | Not disclosed → FY2029 target: 10% or more |
| ROE target | FY2025 actual: 1.2% → FY2029 target: 7% or more（483.3% or more） |
| Self-assessment of PBR and share price | PBR was 0.7x in FY2025. The Company aims to achieve a PBR of 1x or more in FY2029 and improve its PBR. |
| Total investment plan | FY2027–2029: ¥300 million |
| Investment amount by sector | Field Investment in systems related to the membership base and databases / Amount Not disclosed, Field Investment in applying AI to employment-related operations / Amount Not disclosed |
| Segment target | Segment Opportunity Creation / Sales Target FY2029: ¥4,500 million / Profit Target Not disclosed, Segment Platform / Sales Target FY2029: ¥1,000 million / Profit Target Not disclosed |
| Non-financial targets | Indicator Physician information matches / Target value 500,000 matches / Timing FY2029, Indicator Registered physicians / Target value 150,000 physicians / Timing FY2029, Indicator Number of business partners / Target value 45,000 locations / Timing FY2029 |
| Plan assumptions | FY2025 revenue and operating profit are presented excluding services exited in FY2026. Numerical assumptions such as exchange rates: not disclosed. |
| Key initiatives | Expanding and activating the member base, Expanding full-time and regular part-time placements, Monetizing activities that leverage physicians' expertise, Selective focus on growth areas, Use of AI, Activating physician members, Significantly improving productivity, Optimizing the sales promotion ratio, Optimizing workforce efficiency through the use of AI, Using the customer base, Developing agents, Business development and collaboration, Converting into value assets, Shifting the business model, Building a model for circulating physician value overseas |
| Size of the Target Market | Part-time physician market: ¥8.7 billion in 2029, with 763,000 referrals across the overall market. Full-time and regular part-time physician market: ¥23.0 billion in 2029, with 22,000 referrals across the overall market. Physician-targeted market: ¥171.1 billion in 2029. Medical expenses: ¥50 trillion in 2029. Source: Prepared by the Company based on Ministry of Health, Labour and Welfare statistics and data from external research organizations. |
| Risks identified | System Failures, Information Security, Service Operations, Changes to laws and regulations, Overseas Business, Foreign exchange, Competition, Promotion of new services and businesses |
| Publication date | 14 August 2026 |
Items this document does not state (8)
Net income targetROIC targetPayout ratio / DOE policyTreasury share acquisition policyCost of capitalResults under the previous planReason for revision or withdrawalDate of board resolution
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To improve ROE and PBR through revenue growth in areas where physicians are active, stronger earnings power, and capital optimization by concentrating resources on physicians' “activities” while improving the efficiency and optimization of the “infrastructure.”
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.